abstract |
The present invention relates to small molecules according to the formula [I]:which are potent inhibitors of alpha4beta1 mediated adhesion to either VCAM or CS-1 and which can be used for treating or preventing alpha4beta1 adhesion mediated conditions in a mammal such as a human. |